Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, independent of mutation status, when combined with standard-of-care targeted and non-targeted therapies ...
Human induced pluripotent stem cells (hiPSCs) offer a renewable and scalable source for generating brain endothelial cells (BECs), enabling the development of in vitro blood-brain barrier (BBB) models ...
Generating insulin-producing cells (IPCs) poses a significant hurdle in diabetes cell therapy. The liver is an advantageous cell source for pancreatic cell production due to its similar origin, potent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results